PET scans reveal alpha cancer therapy isotope with new algorithm in first human test

AI Summary

Researchers led by Lawrence Berkeley National Laboratory developed a PET imaging technique to detect an isotope used in targeted alpha therapy, testing it in humans for the first time. The algorithm-based advance could help improve diagnosis and support broader use of this emerging cancer treatment.

A research team led by Lawrence Berkeley National Laboratory (Berkeley Lab) has developed a new imaging technique that could allow modern medical scanners to image targeted alpha therapy (TAT), an emerging cancer therapy for the diagnosis and treatment of cancer. The advance could enable the widespread adoption of this new cancer therapy.